Moderna generates $18.4 billion in COVID vaccine sales in 2022
Tweet
Share
E-mail
FILE PHOTO: A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder
(Reuters) - Moderna Inc said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022.
(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna (MRNA) PT Raised to $77 at Piper Sandler
- Moderna outlines three-horizon growth strategy at 2026 Science Day
- Moderna (MRNA) call put ratio 6.7 calls to 1 put with a focus on July 2 weekly 68 and 72 calls as share price up 11.5%
Create E-mail Alert Related Categories
Corporate News, General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
